Oral Herbal Combination Formulation and Hair Growth in Women

Inclusion Criteria: * Age 18 and above * Subject must be able to read and comprehend study procedures and consent forms. * Women with self-perceived hair loss as confirmed by the investigator. * Willing to maintain the same hairstyle, hair color, hair length and hair regimen throughout the study period. Subjects with color-treated hair will have the color treatment performed at the same time interval prior to each visit (if the color treatment was done 1 week prior to Visit 1, it should be repeated 1 week prior to Visit 2). * Willing to keep diet and exercise routine consistent throughout study Exclusion Criteria: * Subjects should be generally healthy and have no smoking history in the past one year. * Subjects must have no history of diabetes, metabolic syndrome, HIV, immune deficiency, autoimmune disease known cardiovascular disease, malignancy, kidney disease, or chronic steroid use. * Women who are pregnant, planning to become pregnant or breastfeeding * Those who are unable to discontinue medicated shampoos or topical scalp medications for two weeks prior to and during the study. * Those who are unable to discontinue supplements containing Eclipta alba, Emblica officinalis, Centella asiatica and Hibiscus sabdariffa for one month prior to starting the study * Those who have a known allergy to Eclipta alba, Emblica officinalis, Centella asiatica or Hibiscus sabdariffa * Use of hair regrowth products in the previous 6 months * Using or planned use of non-breathable wigs * Those with a history of hair transplantation procedure * Presence of other dermatological disorders causing alopecia * Chemotherapy, radiation therapy or laser therapy (of scalp) in the last 6 months * Light therapy in the past 3 months * Participants using hormonal birth control unless on a stable / unchanged regimen for at least 3 months. * Systemic treatment during the last 3 months before study inclusion that could interfere with the study medications (ie, minoxidil, corticosteroids, Aminexil, topical estrogens, ketoconazole, beta blocker, cimetidine, diazoxide, isotretinoin or vitamin A intake \>10,000 IU/d) * Use of ocular prostaglandins for less than 4 months before first study visit * Those that are prisoners or cognitively impaired